loop

Source : Direct Effect of Bevacizumab on Glioblastoma Cell Lines In Vitro Abstract  Bevacizumab is a humanized monoclonal antibody directed against the pro-angiogenic factor vascular and endothelial growth factor-A (VEGF-A) used in the treatment of glioblastomas. Although most patients respond initially to this treatment, studies have shown that glioblastomas eventually Read more…